PROM1 and malignant colon neoplasm: Lin used semiquantitative real-time RT-PCR to quantify CD133 mRNA levels in peripheral blood mononuclear cells from patients with colon cancer and he found that elevated CD133 mRNA levels at ≥4.79 predicted colon cancer recurrence independent of TNM stage IV disease[28].